These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16137490)

  • 1. [Interferon-alpha and development of type 1 diabetes].
    Pinés Corrales PJ; Aragón Valera C; Sanchón Rodríguez R; Ugidos de la Varga L
    Med Clin (Barc); 2005 Sep; 125(7):278-9. PubMed ID: 16137490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoimmune diabetes after treatment with interferon-alpha].
    Mathieu E; Fain O; Sitbon M; Thomas M
    Presse Med; 1995 Jan; 24(4):238. PubMed ID: 7899374
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin-dependent diabetes mellitus induced by interferon-alpha].
    Giuntoli P; Mariani S; Avoli D; Giammarco V
    Minerva Endocrinol; 1995 Dec; 20(4):243-5. PubMed ID: 8709922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis.
    Fabris P; Betterle C; Floreani A; Greggio NA; de Lazzari F; Naccarato R; Chiaramonte M
    Lancet; 1992 Aug; 340(8818):548. PubMed ID: 1354296
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes mellitus and interferon-alpha therapy.
    Murakami M; Iriuchijima T; Mori M
    Ann Intern Med; 1995 Aug; 123(4):318. PubMed ID: 7611607
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversible diabetes in patient with AIDS-related Kaposi's sarcoma treated with interferon alpha-2a.
    Gori A; Caredda F; Franzetti F; Ridolfo A; Rusconi S; Moroni M
    Lancet; 1995 Jun; 345(8962):1438-9. PubMed ID: 7760627
    [No Abstract]   [Full Text] [Related]  

  • 7. [Onset of type 1 diabetes mellitus during combination therapy of chronic hepatitis C with interferon-alpha and ribavirin].
    Christensen UB; Krogsgaard K
    Ugeskr Laeger; 2004 Mar; 166(11):1024-5. PubMed ID: 15049242
    [No Abstract]   [Full Text] [Related]  

  • 8. Fulminant type 1 diabetes caused by peginterferon α-2a therapy in hepatitis C.
    Zheng Y; Wang Z; Xie Z; Dai R; Zhou Z
    J Diabetes; 2018 May; 10(5):419-420. PubMed ID: 29265717
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C.
    Bhatti A; McGarrity TJ; Gabbay R
    Am J Gastroenterol; 2001 Feb; 96(2):604-5. PubMed ID: 11232722
    [No Abstract]   [Full Text] [Related]  

  • 10. [Type 1 diabetes developing during alpha-interferon therapy: report of two cases].
    Vinagre I; Rigla M; Torras X; Enríquez J; Corcoy R
    Endocrinol Nutr; 2010 Oct; 57(8):393-5. PubMed ID: 20462813
    [No Abstract]   [Full Text] [Related]  

  • 11. Exacerbation of psoriasis induced by interferon-alpha treatment for melanoma.
    Tas F; Atsu N
    Cutan Ocul Toxicol; 2016 Mar; 35(1):83-4. PubMed ID: 25799214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.
    Yagyu H; Okada K; Sato S; Yamashita Y; Okada N; Osuga J; Nagasaka S; Sugano K; Ishibashi S
    Diabetes Res Clin Pract; 2012 Mar; 95(3):e52-4. PubMed ID: 22154462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha induced mania during the adjuvant treatment of malignant melanoma.
    Ni Mhaolain AM; Thakore JH
    Ir J Med Sci; 2007; 176(2):137-9. PubMed ID: 17394037
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoimmune response as a side effect of treatment with interferon-α in melanoma: does this have prognostic implications?
    Palacios-Álvarez I; Román-Curto C; Mir-Bonafé JM; Cañueto J; Usero-Bárcena T; Fernández-López E
    Int J Dermatol; 2015 Mar; 54(3):e91-3. PubMed ID: 25521221
    [No Abstract]   [Full Text] [Related]  

  • 15. Alpha interferon in systemic sclerosis.
    Shah VM; Mangat GK; Joshi VR
    J Assoc Physicians India; 2001 Jun; 49():676-7. PubMed ID: 11584956
    [No Abstract]   [Full Text] [Related]  

  • 16. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
    Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica in patients with increased interferon alpha concentrations.
    Williams J; McGlasson S; Irani S; Duffy D; Crow Y; Hunt D;
    Lancet Neurol; 2020 Jan; 19(1):31-33. PubMed ID: 31839246
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of chronic hepatitis C developing insulin-dependent diabetes, thyroid autoimmunity and stiff-person syndrome as complications of interferon therapy.
    Scavone G; Zaccardi F; Manto A; Caputo S; Pitocco D; Ghirlanda G
    Diabetes Res Clin Pract; 2010 Aug; 89(2):e36-8. PubMed ID: 20541278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare form of diabetes and a rare complication of treatment.
    Ma W; Yuan X; Wu X; Li Y; Xiao X; Zhang H; Ping F; Yang H
    Diabet Med; 2020 Nov; 37(11):1954-1955. PubMed ID: 32614974
    [No Abstract]   [Full Text] [Related]  

  • 20. How to manage melanoma in a psoriatic patient.
    Papadavid E; Psyrri A; Pectasides D; Katoulis A; Balamoti E; Dalamaga M; Stavrianeas N
    Dermatology; 2008; 216(3):277-8. PubMed ID: 18196939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.